Key Points Pfizer and Novo Nordisk have underperformed the market over the past year.But both should remain major players in ...

Stay updated with real-time stock market news, Sensex & Nifty movements, top gainers and losers, expert analysis, IPO updates ...

In July 2025, global markets have been navigating a complex landscape marked by new U.S. tariff announcements and mixed economic signals, with the Nasdaq Composite Index showing resilience amidst ...

In a recent market update, Goldman Sachs raised its year-end forecast for the S&P 500 (SPX) to 6,900 by year-end, up from a ...

Australian shares have rebounded impressively since April, but the real test will be the upcoming earnings season.

Highlighted opportunities include NANO Nuclear Energy's niche potential, Christian Dior SE's LVMH exposure, and Harrow's ...

Simulations Plus Inc. reported lower than expected sales and reduced guidance due to cautious biopharma spending.

Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...

These ASX 100 shares could rise in July after a very different past year. Here's what to consider about the two.

Revvity is all set to release its fiscal second-quarter earnings later this month, and analysts project a single-digit ...

Bourse ends at record in strongest session in three months. BHP rallies as CEO says China demand ‘resilient’. CSL posts its ...

U.S. Bancorp notched a rise in earnings for the latest quarter as it benefited from a lower loan-loss provision and growth in fee income. The healthcare-products maker trimmed and narrowed its ...